Randomized prospective study of effects of benazepril in renal transplantation: an analysis of safety and ef cacy. Clin Exper Nephrol. 2002;6:242 247. 348. Trivedi H, Lal SM. A prospective, randomized, open labeled crossover trial of fosinopril and theophylline in post renal transplant erythrocytosis. Ren Fail. 2003;25:77 86. 349. Zhang ZH, Zhang WD, Yao K. Treatment of chronic allograft nephropathy with combination of enalapril and bailing capsule. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2008;28:806 809 [in Chinese]. 350. Vanrenterghem Y, Waer M, De Keyser P, et al. Controlled trial of the protective effect of dihydroergotoxine (Hydergine) on cyclosporine- associated nephrotoxicity in renal graft recipients. Transplantation Proc. 1988;20:615 617. 351. Tylicki L, Biedunkiewicz B, Chamienia A, et al. Randomized placebo- controlled study on the effects of losartan and carvedilol on albuminuria in renal transplant recipients. Transplantation. 2006;81:52 56. 352. Medeiros M, Velasquez-Jones L, Hernandez AM, et al. Randomized controlled trial of mineralocorticoid receptor blockade in children with chronic kidney allograft nephropathy. Clin J Am Soc Nephrol. 2017;12: 1291 1300. 353. Axelrod DA, Schnitzler MA, Xiao H, et al. An economic assessment of contemporary kidney transplant practice. Am J Transplant. 2018;18: 1168 1176. references www.kidney-international.org 354. Chung R, Howard K, Craig JC, et al. Economic evaluations in kidney transplantation: frequency, characteristics, and quality-a systematic review. Transplantation. 2014;97:1027 1033. 355. Wuhl E, Witte K, Soergel M, et al. Distribution of 24-h ambulatory blood pressure in children: normalized reference values and role of body dimensions. J Hypertens. 2002;21:1995 2007. 356. Lurbe E, Agabiti-Rosei E, Cruickshank JK, et al. 2016 European Society of Hypertension guidelines for the management of high blood pressure in children and adolescents. J Hypertens. 2016;34:1887 1920. 357. Simonetti GD, Santoro L, Ferrarini A, et al. Systemic hypertension and proteinuria in childhood chronic renal parenchymal disease: role of antihypertensive drug management. 